FREMONT, Calif., Oct. 12 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that Gary P. Schroth, Ph.D., who helped to pioneer the use of next generation sequencing for gene expression at Illumina, Inc., has joined the company as Senior Vice President, Genomics Research and Applications, a new position created to build on the company's technology leadership in Real-Time PCR.
Dr. Schroth joins WaferGen from Illumina where he was serving as Senior Director, Research and Development. He will oversee the company's biology and chemistry research, the development of new genomic applications, and the SmartChip Gene-Expression Profiling Services offered by WaferGen scientists at the company's headquarters facility in Fremont, Calif. He will report directly to Mona Chadha, Chief Operating Officer and Executive Vice President.
"The WaferGen SmartChip Real-Time PCR platform addresses the growing need for validation of vast quantities of information being discovered through the use of next-generation sequencing," said Alnoor Shivji, chairman and CEO. "Gary will be an enormous asset to expand the further development and adoption of our platform into discovery and validation markets. He brings more than 15 years of genomic research and leadership experience to WaferGen. In addition to his accomplishments as an R&D leader in a variety of roles at successful life sciences companies, he championed the development of gene expression applications using DNA sequencing. His research in the field of gene expression analysis using microarrays, PCR and next-generation sequencing resulted in numerous publications and patents that span the field of genomic analysis."
"I am very excited to join the WaferGen team and help develop no
|SOURCE WaferGen Biosystems, Inc.|
Copyright©2010 PR Newswire.
All rights reserved